Boardroom Alpha
Research library
SPACs · Oct 26, 2026

SPAC Market Update October 26, 2026: OACC Extension Clears with $122M Redemptions, AMAN-Corxel Deal

Oaktree Acquisition Corp III Life Sciences (OACC) won approval to extend its deadline to May 25, 2027, with $122M removed from trust and 11,331,102 shares redeemed. Separately, Amanat Acquisition Corp (AMAN) announced a merger with Corxel Pharmaceuticals, a…

SPAC IPO Update — October 26, 2026

No SPAC IPOs priced on October 26, 2026; October MTD now stands at 4 IPOs totaling $491M over 26 sessions.

SPAC IPO Count

Monthly IPOs (last 13 months)
Latest: 4•Prior: 5•MoM: -1
14
Oct ’25
10
Nov ’25
22
Dec ’25
24
Jan ’26
27Peak
Feb ’26
11
Mar ’26
16
Apr ’26
20
May ’26
19
Jun ’26
18
Jul ’26
12
Aug ’26
5
Sep ’26
4
Oct ’26
Source: Boardroom Alpha
IPO Activity SnapshotMonth-to-date: 4 IPOs ($491M) vs. first 26 days of last month 5 ($940M) · 12-mo avg: 16/mo
$ totals include underwriter over-allotment.
New SPAC IPOs
Date Ticker Issuer IPO Size Trust Funding
Oct 16 TCXB TCGX ACQUISITION CORP II $100M 100.0%
Source: Boardroom Alpha

Daily SPAC Update — October 26, 2026

SPAC VOTE RESULTS
OAKTREE ACQUISITION CORP III LIFE SCIENCES (OACC) * Extend to May 25, 202711,331,102 redeemed · $122,432,557 removed · trust $10.81
MELAR ACQUISITION CORP I (MACI) * Deal Approved with Everli Global Inc.3,852,564 redeemed

SPAC DEALS ANNOUNCED
October 26 | Amanat Acquisition Corp (AMAN) + Corxel PharmaceuticalsCorxel Pharmaceuticals is a clinical-stage biopharmaceutical company that develops oral medicines for obesity and related cardiometabolic conditions. Its lead product candidate, CX11, is a once-daily oral GLP-1 receptor agonist that has completed Phase 2 clinical development in the United States and Phase 3 clinical development in Asia. The company is also advancing CX12, an investigational oral amylin receptor agonist currently in preclinical development.
October 21 | Apex Tech Acquisition Inc (TRAD) + Korai Flix IncKorai Flix Inc is an interactive online entertainment platform headquartered in South Korea. It offers AI-powered interactive content experiences, including AI short dramas and AI companion avatars. The platform serves a growing user base across Asia, providing personalized and immersive entertainment experiences.

SPAC DEAL & EXTENSION VOTES SET
Blue Acquisition Corp (BACC) * DEAL VOTE SET: November 17, 2026 * trust $10.52

SPAC EXTENSIONS
RIBBON ACQUISITION CORP (RIBB) * Extension FilingRibbon Acquisition Corp deposits $125,000 to extend its business combination deadline to November 15, 2026.
INTERNATIONAL MEDIA ACQUISITION CORP (IMAQ) * Extension FilingSPAC extends deadline to December 2, 2026 via a $2,000 extension payment deposited to the trust.
UY SCUTI ACQUISITION CORP (UYSC) * Extension FilingUYSC extends business combination deadline via promissory notes to Isdera HK and Xinghui; Joinder/First Amendment add Isdera entities to the Merger Agreement.

SEPARATE WARRANTS/RIGHTS
October 23: PINE TREE ACQUISITION CORP (PAXG)

OTHER SPAC NEWS
AMANAT ACQUISITION CORP (AMAN) * Merger Agreement
AMANAT ACQUISITION CORP (AMAN) * Investor Deck
BOLD EAGLE ACQUISITION CORP (BEAG) * Media TranscriptREDLattice-Bold Eagle merger: $1.25B EV, 100% equity rollover, $60M cash at $10/sh; extension vote; close by year-end.
INFLECTION POINT ACQUISITION CORP VI (IPFX) * Merger Agreement AmendmentAmendment to move listing to NYSE and adjust PubCo board size, subject to Quantum Space approval.
STARRY SEA ACQUISITION CORP (SSEA) * Redemption Update * 3,896,270 redeemedAmendment corrects the redemption tender count to 3,896,270 shares; monthly extension fee is $60,000 per one-month extension following the Oct 19 Extension Meeting.

SPAC LISTING RULE NOTICES
ARC GROUP SECURITIES ACQUISITION I (FJDI) * Listing Rule NoticeNasdaq notified ARC Group that warrants’ value fell below $1 million, creating a deficiency. ARC has 45 days to propose a cure plan, with possible extensions and delisting risk limited to the warrants.

SPAC Executive & Director Moves — October 26, 2026

SPAC Executive & Director Moves
Company Ticker Moves
ART TECHNOLOGY ACQUISITION CORP ARTCU
  • Walter T. Beach resigned as a member of Art Technology Acquisition Corp.’s board of directors effective immediately on October 20, 2026.  (view source)
Source: SEC EDGAR filings via Boardroom Alpha

SPAC Movers — October 26, 2026

YESTERDAY’S TOP SPAC GAINERS
Company Ticker Change Price Stage
BLACK HAWK ACQUISITION CORP BKHA 25.9% $ 5.40 Announced
CALISA ACQUISITION CORP ALIS 9.4% $ 8.96 Announced
QUETTA ACQUISITION CORP QETA 3.1% $ 11.55 Announced
TCGX ACQUISITION CORP TCGX 0.7% $ 10.10 Announced
PALOMA ACQUISITION CORP I PALO 0.5% $ 10.03 Pre-Deal
YESTERDAY’S TOP SPAC LOSERS
Company Ticker Change Price Stage
RF ACQUISITION CORP II RFAI -24.2% $ 26.15 Announced
RIBBON ACQUISITION CORP RIBB -7.2% $ 5.67 Announced
FUTURE VISION II ACQUISITION CORP FVN -6.9% $ 11.15 Announced
MELAR ACQUISITION CORP I MACI -3.2% $ 11.00 Announced
RISING DRAGON ACQUISITION CORP RDAC -2.0% $ 4.90 Announced
Source: Boardroom Alpha market data

Frequently Asked Questions

  • How much was redeemed at OACC‘s extension vote?
    Oaktree Acquisition Corp III Life Sciences (OACC) had 11,331,102 shares redeemed, removing $122M from trust. The extension approval pushed its deadline to May 25, 2027.
  • What deal did Amanat Acquisition Corp announce on October 26, 2026?
    Amanat Acquisition Corp (AMAN) announced a merger with Corxel Pharmaceuticals, a clinical-stage biopharmaceutical company developing oral medicines for obesity and related cardiometabolic conditions.
  • What happened at Melar Acquisition Corp I’s deal vote?
    Melar Acquisition Corp I (MACI) received approval for its combination with Everli Global Inc. Shareholders redeemed 3,852,564 shares in the vote.
  • How many SPAC IPOs priced in October 2026 through October 26?
    Four SPAC IPOs priced for $491M through October 26, 2026, compared with five IPOs for $940M over the same first 26 days of September 2026.


Get it in your inbox

The Daily SPAC Update in your inbox

Every IPO, vote, and DeSPAC close — analyzed daily for finance professionals.

ShareXLinkedIn

Published Oct 26, 2026

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer